Systems analysis and the prediction and prevention of Type 2 diabetes mellitus

Current Opinion in Biotechnology

Volumn 28, Issue , 2014, Pages 165-170

  Bergman, Richard N ^a   Stefanovski, Darko ^a   Kim, Stella P ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SYSTEMS ANALYSIS;

CLINICAL ASSESSMENTS; CLINICAL SETTINGS; DISEASE RISKS; GENOME-WIDE ASSOCIATION STUDIES; GLUCOSE TOLERANCE; HYPERBOLIC LAW; TYPE 2 DIABETES MELLITUS; TYPE-2 DIABETES;

RISK ASSESSMENT;

AMINO ACID DERIVATIVE; BILE ACID; FATTY ACID DERIVATIVE; GLUCAGON LIKE PEPTIDE 1; GLUCOKINASE; GLUCOSE; GROWTH HORMONE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HYDROCORTISONE; INSULIN;

CLINICAL ASSESSMENT TOOL; DISPOSITION INDEX; GCK GENE; GENE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GLUCOSE TOLERANCE; HIGH RISK PATIENT; HNF1A GENE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; METABOLOMICS; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEM ANALYSIS;

DIABETES MELLITUS, TYPE 2; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INSULIN; METABOLOMICS; PREDICTIVE VALUE OF TESTS; SYSTEMS BIOLOGY;

EID: 84903377582     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2014.05.007     Document Type: Review

References (34)

1. Centers for Disease Control and Prevention National Diabetes Surveillance System.
2. The White House, Office of the Press Secretary National Diabetes Month, 2013 [Press release] 2013, Retrieved from http://www.whitehouse.gov/the-press-office/2013/10/31/presidential-proclamation-national-diabetes-month-2013.
3. Timmer J. Definition of Systems Biology 2014, Retrieved from http://www.zbsa.de/Systems-Biology/defn.
4. Perreault L., Pan Q., Mather K.J., Watson K.E., Hamman R.F., Kahn S.E. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 2012, 379:2243-2251. Diabetes Prevention Program Research Group.
5. Kirk E.P., Klein S. Pathogenesis and pathophysiology of the cardiometabolic syndrome. J Clin Hypertens (Greenwich) 2009, 12:761-765.
6. Pollack A. A.M.A. recognizes obesity as a disease. N Y Times 2013, June 18. Retrieved from http://www.nytimes.com/2013/06/19/business/ama-recognizes-obesity-as-a-disease.html.
7. Igel L.I., Powell A.G., Apovian C.M., Aronne L.J. Advances in medical therapy for weight loss and the weight-centric management of type 2 diabetes mellitus. Curr Atheroscler Rep 2012, 14:60-69.
8. Ribaric G., Buchwald J.N., McGlennon T.W. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg 2013, 10.1007/s11695-013-1160-3.
9. Buchanan T.A., Xiang A.H., Peters R.K., Kjos S.L., Marroquin A., Goico J., Ochoa C., Tan S., Berkowitz K., Hodis H.N., Azen S.P. Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002, 51:2796-2803.
10. Poulsen P., Kyvik K.O., Vaag A., Beck-Nielsen H. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance - a population-based twin study. Diabetologia 1999, 42:139-145.
11. Pihoker C., Gilliam L.K., Ellard S., Dabelea D., Davis C., Dolan L.M., Greenbaum C.J., Imperatore G., Lawrence J.M., Marcovina S.M., Mayer-Davis E., Rodriguez B.L., Steck A.K., Williams D.E., Hattersley A.T. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. SEARCH for Diabetes in Youth Study Group. J Clin Endocrinol Metab 2013, 98:4055-4062.
12. Greenawalt D.M., Sieberts S.K., Cornelis M.C., Girman C.J., Zhong H., Yang X., Guinney J., Qi L., Hu F.B. Integrating genetic association, genetics of gene expression, and single nucleotide polymorphism set analysis to identify susceptibility loci for type 2 diabetes mellitus. Am J Epidemiol 2012, 176:423-430.
13. Schmid R., Vollenweider P., Bastardot F., Vaucher J., Waeber G., Marques-Vidal P. Current genetic data do not improve the prediction of type 2 diabetes mellitus: the CoLaus study. J Clin Endocrinol Metab 2012, 97. E1338-41.
14. Dagogo-Jack S. Metabolomic prediction of diabetes and cardiovascular risk. Med Princ Pract 2012, 21:401-403.
15. Shah S.H., Svetkey L.P., Newgard C.B. Branching out for detection of type 2 diabetes. Cell Metab 2011, 13:491-492.
16. Defronzo R.A. Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009, 58:773-795.
17. Shah S.H., Crosslin D.R., Haynes C.S., Nelson S., Turer C.B., Stevens R.D., Muehlbauer M.J., Wenner B.R., Bain J.R., Laferrère B., Gorroochurn P., Teixeira J., Brantley P.J., Stevens V.J., Hollis J.F., Appel L.J., Lien L.F., Batch B., Newgard C.B., Svetkey L.P. Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia 2012, 55:321-330.
18. Newgard CB, An J., Bain J.R., Muehlbauer M.J., Stevens R.D., Lien L.F., Haqq A.M., Shah S.H., Arlotto M., Slentz C.A., Rochon J., Gallup D., Ilkayeva O., Wenner B.R., Yancy W.S., Eisenson H., Musante G., Surwit R.S., Millington D.S., Butler M.D., Svetkey L.P. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009, 9:311-326.
19. Xiao F., Huang Z., Li H., Yu J., Wang C., Chen S., Meng Q., Cheng Y., Gao X., Li J., Liu Y., Guo F. Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes 2011, 60:746-756.
20. Dimas A.S., Lagou V., Barker A., Knowles J.W., Magi R., Hivert M., et al. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 2014, 63:2158-2171.
21. Lorenzo C., Wagenknecht L.E., Rewers M.J., Karter A.J., Bergman R.N., Hanley A.J., Haffner S.M. Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010, 33:2098-2103.
22. Himsworth H. Diabetes mellitus: its differentiation into insulin-sensitive and insulin insensitive types. Lancet 1936, 227:127-130.
23. Cerasi E., Luft R., Efendic S. Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study. Diabetes 1972, 21:224-234.
24. Bergman R.N., Phillips L.S., Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981, 68:1456-1467.
25. Bergman R.N., Ader M., Huecking K., Van Citters G. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 2002, 51:S212-S220.
26. Kodama K., Tojjar D., Yamada S., Toda K., Patel C.J., Butte A.J. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care 2013, 36:1789-1796.
27. Bergman R.N. Orchestration of glucose homeostasis: from a small acorn to the California oak. Diabetes 2007, 56:1489-1501.
28. Kahn S.E., Prigeon R.L., McCulloch D.K., Boyko E.J., Bergman R.N., Schwartz M.W., Neifing J.L., Ward W.K., Beard J.C., Palmer J.P., et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993, 42:1663-1672.
29. Bergman R.N. Quantitative approaches to pathogenesis of age-related metabolic conditions. Biomedical Advances in Aging 1990, 229-245. Plenum Press, New York. A.L. Goldstein (Ed.).
30. Corkey B.E. Diabetes: have we got it all wrong? Insulin hypersecretion and food additives: cause of obesity and diabetes?. Diabetes Care 2012, 35:2432-2437.
31. Kim S.P., Catalano K.J., Hsu I.R., Chiu J.D., Richey J.M., Bergman R.N. Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia. Am J Physiol Endocrinol Metab 2007, 292:E1590-E1598.
32. Weyer C., Bogardus C., Mott D.M., Pratley R.E. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999, 104:787-794.
33. Jonsson A., Isomaa B., Tuomi T., Taneera J., Salehi A., Nilsson P., Groop L., Lyssenko V. A variant in the KCNQ1 gene predicts future type 2 diabetes and mediates impaired insulin secretion. Diabetes 2009, 58:2409-2413.
34. Defronzo R.A., Tripathy D., Schwenke D.C., Banerji M., Bray G.A., Buchanan T.A., Clement S.C., Henry R.R., Kitabchi A.E., Mudaliar S., Ratner R.E., Stentz F.B., Musi N., Reaven P.D., Gastaldelli A. Prediction of diabetes based on baseline metabolic characteristics in individuals at high risk. Diabetes Care 2013, 36:3607-3612. ACT NOW Study.